Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
346 Enhanced anti-tumor activity of HBsAg specific TCR-T (SCG101) in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) by preventing T cell exhaustion through PD-1/PD-L1 axis blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.